The role of IL6 cytokines in acute cardiac allograft rejection

Transplant Immunology

Volumn 9, Issue 2-4, 2002, Pages 115-120

  Deng, Mario C ^a   Plenz, Gabriele ^b   Labarrere, Carlos ^c   Marboe, Chuck ^d   Baba, Hideo A ^e   Erren, Michael ^f   Itescu, Silviu ^d  

^a Department of Medicine   (United States)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c METHODIST RESEARCH INSTITUTE   (United States)

^d New York Presbyt Hosp ^*  (United States)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f Institute of Laboratory Medicine   (Germany)

Author keywords

Cytokines; Graft rejection; Transplantation

Indexed keywords

CYCLOSPORIN; CYTOKINE; GLUCOCORTICOID; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; MESSENGER RNA; METHYLPREDNISOLONE; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

CONFERENCE PAPER; CYTOKINE RELEASE; DISEASE PREDISPOSITION; EVIDENCE BASED MEDICINE; EVOLUTION; GENETIC SELECTION; GRAFT REJECTION; HEART DISEASE; HEART TRANSPLANTATION; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; INFLAMMATION; LYMPHOCYTE FUNCTION; METABOLIC REGULATION; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION INITIATION; TRANSLATION INITIATION; ACUTE DISEASE; ALLOTRANSPLANTATION; ANIMAL; IMMUNOLOGY; PHYSIOLOGY; REVIEW;

ACUTE DISEASE; ANIMALS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INTERLEUKIN-6; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035746250     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(02)00004-7     Document Type: Conference Paper

References (37)

1. Immune mechanisms of acute rejection
2. Transplantation and cytokines
3. Cytokines as mediators of organ graft rejection and tolerance
4. Gp130 and the IL6 family of cytokines
5. IL6-type cytokine signalling through the gp130/Jak/STAT pathway
6. Impaired immune and acute-phase responses in IL6-deficient mice
7. IL6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system
8. The role of IL6 in mucosal IgA antibody responses in vivo
9. + T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans
10. Role of IL6 and its soluble receptor in induction of chemokines and leukocyte recruitment
11. Defective inflammatory response in interleukin 6-deficient mice
12. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL1: A study on IL6-deficient mice
13. IL6-deficient mice are highly susceptible to Listeria monocytogenes infection: Correlation with inefficient neutrophilia
14. Leukemia inhibitory factor gene improves skin allograft survival in the mouse model
15. Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects
16. Regulated expression of gp130 and IL6 receptor alpha chain in T cell maturation and activation
17. Signaling and transcription in T-helper development
18. Evolutionary adaptation of inflammatory immune responses in human beings
19. Expression of cytokine genes in human cardiac allografts: Correlation of IL6 and transforming growth factor-beta (TGF-beta) with histological rejection
20. In situ expression of cytokines in human heart allografts
21. The intragraft cytokine mRNA pattern reflects the efficacy of steroid antirejection therapy
22. The paradox of cytokine monitoring-predictor of immunologic activity as well as immunologic silence following cardiac transplantation
23. Evaluation of plasma levels of tumour necrosis factor alpha and IL6 as rejection markers in a cohort of 142 heart-grafted patients followed by endomyocardial biopsy
24. Cytokine gene expression profiles in human endomyocardial biopsy (EMB) derived lymphocyte cultures and in EMB tissue
25. Cytokine messenger RNA expression by donor-specific cytotoxic T-cell clones after allogeneic heart transplantation
26. Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients
27. Coronary sinus sampling of cytokines after heart transplantation: Evidence for macrophage activation and IL4 production within the graft
28. Endothelial activation and cytokine expression in human acute cardiac allograft rejection
29. The relation of IL6, tumor necrosis factor-alpha, IL2, and IL2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation
30. T-cell and monocyte subsets, inflammatory molecules, rejection, and hemodynamics early after cardiac transplantation
31. Metallothionein: Localization in human transplant endomyocardium, relation to cytokines and allograft function
32. Serial measurements of IL6, IL8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients
33. Different patterns in donor-specific production of T-helper 1 and 2 cytokines by cells infiltrating the rejecting cardiac allograft
34. Suppression of allograft responses induced by IL6, which selectively modulates IFNg but not IL2 production. Suppression of allograft responses induced by IL6, which selectively modulates IFNg but not IL2 production
35. Low multiplicity CMV infection of human aortic smooth muscle cells increases levels of major histocompatibility complex class I antigens and induces a proinflammatory cytokine milieu in the absence of cytopathology
36. Cytokines and their receptors: Molecular mechanism of IL6 gene expression by glucocorticoids
37. Heart transplant rejection with hemodynamic compromise: A multiinstitutional study of the role of endomyocardial cellular infiltrate. Cardiac Transplant Research Database